Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
LR-19155 by LG Chem for Non-Small Cell Lung Cancer: Likelihood of Approval
LR-19155 is under clinical development by LG Chem and currently in Phase I for Non-Small Cell Lung Cancer. According to...
LR-19155 by LG Chem for Transitional Cell Carcinoma (Urothelial Cell Carcinoma): Likelihood of Approval
LR-19155 is under clinical development by LG Chem and currently in Phase I for Transitional Cell Carcinoma (Urothelial Cell Carcinoma)....
LR-19155 by LG Chem for Renal Cell Carcinoma: Likelihood of Approval
LR-19155 is under clinical development by LG Chem and currently in Phase I for Renal Cell Carcinoma. According to GlobalData,...
LR-19155 by LG Chem for Metastatic Melanoma: Likelihood of Approval
LR-19155 is under clinical development by LG Chem and currently in Phase I for Metastatic Melanoma. According to GlobalData, Phase...